Abstract:Data on the pharmacological management of acute agitation in schizophrenia are scarce. The aim of this study is to investigate the prescription practices in the treatment of agitation in Chinese patients with schizophrenia. We conducted a large, multicenter, observational study in 14 psychiatry hospitals in China. Newly hospitalized schizophrenia patients with the PANSS-EC total score ≥ 14 and a value ≥4 on at least one of its five items were included in the study. Their drug treatments of the first 2 weeks in hospital were recorded by the researchers. Eight hundred and 53 patients enrolled in and 847 (99.30%) completed the study. All participants were prescribed antipsychotics, 40 (4.72%) were prescribed benzodiazepine in conjunction with antipsychotics and 81 were treated with modified electric convulsive therapy (MECT). Four hundred and 12 (48.64%) patients were prescribed only one antipsychotic, in the order of olanzapine (120 patients, 29.13%), followed by risperidone (101 patients, 24.51%) and clozapine (41 patients, 9.95%). About 435 (51.36%) participants received antipsychotic polypharmacy, mostly haloperidol + risperidone (23.45%), haloperidol+ olanzapine (17.01%), olanzapine+ ziprasidone (5.30%), haloperidol + clozapine (4.37%) and haloperidol + quetiapine (3.90%). Binary logistic regression analysis suggests that a high BARS score (OR 2.091, 95%CI 1.140–3.124), severe agitation (OR 1.846, 95%CL 1.266–2.693), unemployment or retirement (OR 1.614, 95%CL 1.189–2.190) and aggressiveness on baseline (OR 1.469, 95%CL 1.032–2.091) were related to an increased antipsychotic polypharmacy odds. Male sex (OR 0.592, 95%CL 0.436–0.803) and schizophrenia in older persons (age ≥ 55 years, OR 0.466, 95%CL 0.240–0.902) were less likely to be associated with antipsychotic polypharmacy. The present study demonstrates that monotherapy and polypharmacy display equally common patterns of antipsychotic usage in managing agitation associated with schizophrenia in China. The extent and behavioral activities of agitation and several other factors were associated with polypharmacy.

From strict quarantine to an optimized policy: Are we psychologically prepared?

Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care

Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studies

Clozapine in Schizophrenia and Its Association with Treatment Satisfaction and Quality of Life: Findings of the Three National Surveys on Use of Psychotropic Medications in China (2002–2012)

Use of Clozapine in Older Asian Patients with Schizophrenia Between 2001 and 2009

Investigation on clozapine use in patients with schizophrenia

History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study

Socioeconomic Factors Influencing Antipsychotic Prescription for Schizophrenia Inpatients in China: a Cross-Sectional Study.

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China.

Patterns of Antipsychotic Prescriptions in Patients with Schizophrenia in China: A National Survey

[Population Pharmacokinetics Research of Clozapine in Chinese Schizophrenic Patients].

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

Individual differences in the pharmacokinetics of clozapine in healthy Chinese adults

The relationship of cardiovascular disease risk, clozapine antipsychotic use and cognitive function in a large Chinese schizophrenia cohort

Gender, Age, Smoking Behaviour And Plasma Clozapine Concentrations In 193 Chinese Inpatients With Schizophrenia

DRUG-NAIVE FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS: PHARMACOLOGICAL TREATMENT PRACTICES IN INPATIENT UNITS IN HUNAN PROVINCE, CHINA

Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort

Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Clozapine Use for Bipolar Disorder

Psychiatrists' views on clozapine prescribing in Ireland